MedTrace Logo

Early Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients With LD SCLC

NCT02058056 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2020-01-29

No results posted yet for this study

Summary

The main objective of this trial is to assess NCF after early HA-PCI concomitant to the second cycle of CHT and to tRT for patients with LD SCLC.

Conditions

  • Small-Cell Lung Cancer

Interventions

RADIATION

Irradiation: HA-PCI

25 Gy in 10 daily factions, five times a week

Sponsors & Collaborators

  • Swiss Cancer Institute

    lead OTHER

Principal Investigators

  • Francesca Caparrotti, MD · Hôpitaux Universitaires de Genève, Genève

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-11
Primary Completion
2018-06-07
Completion
2018-12-03

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02058056 on ClinicalTrials.gov